Keyphrases
South Africa
100%
South African
32%
HIV Vaccine
19%
Pretoria
18%
HIV Prevention
17%
Vaccine Trial
16%
AIDS/HIV
15%
Vaccination
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
13%
Placebo
11%
Acinetobacter Baumannii (A. baumannii)
10%
HIV Infection
10%
Adverse Events
9%
Sexually Transmitted Infections
9%
Academic Hospital
9%
Cancer Therapy
8%
Pregnant Women
8%
Men Who Have Sex with Men
8%
HIV-1 Infection
8%
Healthcare Workers
8%
COVID-19
8%
HIV Status
8%
Whole Genome Sequencing
7%
Unblinding
7%
Risk Behavior
7%
Ad26
7%
Resistance Genes
6%
Immunization
6%
Hepatitis B Virus
6%
Cryptococcal Meningitis
6%
Candidemia
6%
Antibiotic Resistance
6%
Vaccine Effectiveness
6%
Africa
6%
Fungemia
5%
S Vaccine
5%
Candida Auris
5%
South African Men
5%
Cross-sectional Observational Study
5%
Tertiary Hospital
5%
Carbapenem-resistant Acinetobacter Baumannii
5%
Randomized Placebo-controlled Trial
5%
Antibacterial Activity
5%
Streptococcus Agalactiae
5%
Multidrug-resistant Tuberculosis (MDR-TB)
5%
Neonatal Unit
5%
Southern African
5%
Vaccination Protocols
5%
Quantitative PCR
5%
Chlamydia Trachomatis
5%
Laboratory-based Surveillance
5%
BlaOXA
5%
CD4+ T
5%
HIV Testing
5%
Sexual Behavior
5%
Immunization Services
5%
Medicine and Dentistry
Human Immunodeficiency Virus
37%
Adverse Event
18%
Infection
16%
Placebo
13%
Human Immunodeficiency Virus Vaccine
10%
Prevalence
8%
Neisseria gonorrhoeae
7%
Chlamydia Trachomatis
7%
Clinical Trial
7%
Cryptococcal Meningitis
6%
Adolescence
6%
Serotype
6%
High Risk Behavior
6%
Vaccine
6%
Human Immunodeficiency Virus 1 Infection
6%
COVID-19
5%
Observational Study
5%
Health System
5%
Men Who Have Sex with Men
5%
Human Immunodeficiency Virus Infection
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Disease
5%